BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 6308314)

  • 1. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
    Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
    Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Four cases of diffuse bone metastasis with increased uptake in 99mTc-MDP bone scintigraphy].
    Dannoura R; Morita S; Kikuchi S; Ohta M; Ohtake H
    Kaku Igaku; 1984 Nov; 21(11):1521-5. PubMed ID: 6241644
    [No Abstract]   [Full Text] [Related]  

  • 4. New vistas on bone scintigraphy.
    Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer].
    Kosuda S; Kondo M; Masaki H; Endo M; Ando Y; Takagi Y; Kubo A; Hashimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 May; 42(5):454-66. PubMed ID: 6217442
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of non-staging skeletal scintigraphy in breast cancer.
    Kunkler IH; Merrick MV
    Clin Radiol; 1986 Nov; 37(6):561-2. PubMed ID: 3098492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical comparison of MDP and DMAD.
    Rosenthall L; Stern J; Arzoumanian A
    Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the performance and interpretation of bone scans.
    Muroff LR
    Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
    [No Abstract]   [Full Text] [Related]  

  • 10. [Giant cell tumor of the bone (author's transl)].
    Hikita C; Yamagishi Y; Okuyama A
    Rinsho Hoshasen; 1981 Aug; 26(8):907-8. PubMed ID: 6457188
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
    Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
    Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radiological diagnosis of bone metastasis of hepatoma].
    Nakata H; Kaneko K; Nakayama C; Kimoto T; Nakayama T
    Rinsho Hoshasen; 1984 Aug; 29(8):855-8. PubMed ID: 6096597
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical comparison of Tc-99m HEDP and Tc-99m MDP.
    Coupal JJ; Kim EE
    J Nucl Med; 1979 Aug; 20(8):896-7. PubMed ID: 120424
    [No Abstract]   [Full Text] [Related]  

  • 14. Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by (99m)Tc-MDP bone scintigraphy.
    Yang S; Dong Q; Yao M; Shi M; Ye J; Zhao L; Su J; Gu W; Xie W; Wang K; Du Y; Li Y; Huang Y
    Nucl Med Biol; 2009 Apr; 36(3):313-21. PubMed ID: 19324277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal skeletal uptake of labeled leukocytes: infection versus tumor metastasis.
    Wahner-Roedler DL
    J Nucl Med; 1990 Sep; 31(9):1543-7. PubMed ID: 2168474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantification in bone scintigraphy with Tc-99m-phosphonates: determinants and data points].
    Büll U; Reinartz P
    Nuklearmedizin; 2000 Aug; 39(5):N69-71. PubMed ID: 10984892
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
    Pauwels EK; Camps JA; Blom J; Hermans J; Kelly JD; Cumming SA; Blackburn GM; Rashid A
    Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal scintigraphy with technetium diphosphonate in multiple myeloma--a comparison with skeletal x-ray.
    Lindström E; Lindström FD
    Acta Med Scand; 1980; 208(4):289-91. PubMed ID: 6449830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bone scan as a tumour marker in prostatic carcinoma.
    Chisholm GD; Stone AR; Beynon LL; Merrick MV
    Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.